These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16467940)

  • 1. Utilization of 3'-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain.
    Song YL; Tan J; Luo XM; Long YQ
    Org Biomol Chem; 2006 Feb; 4(4):659-66. PubMed ID: 16467940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
    Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
    J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and utilization of chiral alpha-methylated alpha-amino acids with a carboxyalkyl side chain in the design of novel Grb2-SH2 peptide inhibitors free of phosphotyrosine.
    Long YQ; Xue T; Song YL; Liu ZL; Huang SX; Yu Q
    J Med Chem; 2008 Oct; 51(20):6371-80. PubMed ID: 18821748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptides.
    Lee K; Zhang M; Liu H; Yang D; Burke TR
    J Med Chem; 2003 Jun; 46(13):2621-30. PubMed ID: 12801226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
    J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrocyclization in the design of non-phosphorus-containing Grb2 SH2 domain-binding ligands.
    Shi ZD; Wei CQ; Lee K; Liu H; Zhang M; Araki T; Roberts LR; Worthy KM; Fisher RJ; Neel BG; Kelley JA; Yang D; Burke TR
    J Med Chem; 2004 Apr; 47(8):2166-9. PubMed ID: 15056012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
    Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
    J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.
    Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR
    J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements for Tyr in the consensus sequence Y-E-N of a novel nonphosphorylated inhibitor to the Grb2-SH2 domain.
    Long YQ; Yao ZJ; Voigt JH; Lung FD; Luo JH; Burke TR; King CR; Yang D; Roller PP
    Biochem Biophys Res Commun; 1999 Nov; 264(3):902-8. PubMed ID: 10544028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
    Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
    Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of l-3-aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding affinity.
    Song YL; Roller PP; Long YQ
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3205-8. PubMed ID: 15149676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.
    Li P; Zhang M; Peach ML; Zhang X; Liu H; Nicklaus M; Yang D; Roller PP
    Biochem Biophys Res Commun; 2003 Aug; 307(4):1038-44. PubMed ID: 12878216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of a common pathway for the synthesis of high affinity macrocyclic Grb2 SH2 domain-binding peptide mimetics that differ in the configuration at one ring junction.
    Shi ZD; Karki RG; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR
    Chem Biodivers; 2005 Apr; 2(4):447-56. PubMed ID: 17191992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small peptides containing phosphotyrosine and adjacent alphaMe-phosphotyrosine or its mimetics as highly potent inhibitors of Grb2 SH2 domain.
    Liu WQ; Vidal M; Gresh N; Roques BP; Garbay C
    J Med Chem; 1999 Sep; 42(18):3737-41. PubMed ID: 10479306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain.
    Lou YC; Lung FD; Pai MT; Tzeng SR; Wei SY; Roller PP; Cheng JW
    Arch Biochem Biophys; 1999 Dec; 372(2):309-14. PubMed ID: 10600169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic.
    Furet P; García-Echeverría C; Gay B; Schoepfer J; Zeller M; Rahuel J
    J Med Chem; 1999 Jul; 42(13):2358-63. PubMed ID: 10395476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic peptide inhibitors of phosphatidylinositol 3-kinase p85 SH2 domain binding.
    Burke TR; Nomizu M; Otaka A; Smyth MS; Roller PP; Case RD; Wolf G; Shoelson SE
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1148-53. PubMed ID: 8024556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of novel nonpeptide inhibitors of the Src SH2 domain:phosphotyrosine mimetics exploiting multifunctional group replacement chemistry.
    Sundaramoorthi R; Kawahata N; Yang MG; Shakespeare WC; Metcalf CA; Wang Y; Merry T; Eyermann CJ; Bohacek RS; Narula S; Dalgarno DC; Sawyer TK
    Biopolymers; 2003; 71(6):717-29. PubMed ID: 14991680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain.
    Lung FD; Long YQ; Roller PP; King CR; Varady J; Wu XW; Wang S
    J Pept Res; 2001 Jun; 57(6):447-54. PubMed ID: 11437948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.